nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Dry skin—Vemurafenib—melanoma	0.00892	0.0125	CcSEcCtD
Trospium—Endocrine disorder—Temozolomide—melanoma	0.00827	0.0116	CcSEcCtD
Trospium—Photosensitivity reaction—Vemurafenib—melanoma	0.00768	0.0107	CcSEcCtD
Trospium—Infestation NOS—Vemurafenib—melanoma	0.0075	0.0105	CcSEcCtD
Trospium—Infestation—Vemurafenib—melanoma	0.0075	0.0105	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00744	0.0104	CcSEcCtD
Trospium—Bladder pain—Bleomycin—melanoma	0.00734	0.0103	CcSEcCtD
Trospium—Supraventricular tachycardia—Docetaxel—melanoma	0.00695	0.00973	CcSEcCtD
Trospium—Mouth ulceration—Dactinomycin—melanoma	0.00685	0.00958	CcSEcCtD
Trospium—Influenza like illness—Temozolomide—melanoma	0.00665	0.00931	CcSEcCtD
Trospium—Oedema peripheral—Vemurafenib—melanoma	0.00663	0.00928	CcSEcCtD
Trospium—Connective tissue disorder—Vemurafenib—melanoma	0.00662	0.00925	CcSEcCtD
Trospium—Erythema multiforme—Vemurafenib—melanoma	0.00637	0.0089	CcSEcCtD
Trospium—Dry eye—Temozolomide—melanoma	0.00633	0.00885	CcSEcCtD
Trospium—Eye disorder—Vemurafenib—melanoma	0.00629	0.0088	CcSEcCtD
Trospium—Cardiac disorder—Vemurafenib—melanoma	0.00625	0.00874	CcSEcCtD
Trospium—Abnormal vision—Carmustine—melanoma	0.00618	0.00865	CcSEcCtD
Trospium—Angiopathy—Vemurafenib—melanoma	0.00611	0.00854	CcSEcCtD
Trospium—Mediastinal disorder—Vemurafenib—melanoma	0.00607	0.00849	CcSEcCtD
Trospium—Abnormal vision—Temozolomide—melanoma	0.00598	0.00836	CcSEcCtD
Trospium—Rash erythematous—Docetaxel—melanoma	0.00595	0.00832	CcSEcCtD
Trospium—Malnutrition—Vemurafenib—melanoma	0.00586	0.0082	CcSEcCtD
Trospium—Ear pain—Temozolomide—melanoma	0.00583	0.00815	CcSEcCtD
Trospium—Dysgeusia—Vemurafenib—melanoma	0.00574	0.00803	CcSEcCtD
Trospium—Eye pain—Carmustine—melanoma	0.0057	0.00797	CcSEcCtD
Trospium—Back pain—Vemurafenib—melanoma	0.00567	0.00793	CcSEcCtD
Trospium—Eye pain—Temozolomide—melanoma	0.00551	0.00771	CcSEcCtD
Trospium—Hot flush—Temozolomide—melanoma	0.00532	0.00744	CcSEcCtD
Trospium—Menopausal symptoms—Temozolomide—melanoma	0.00527	0.00737	CcSEcCtD
Trospium—Thirst—Temozolomide—melanoma	0.00523	0.00731	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00496	0.00693	CcSEcCtD
Trospium—Anaphylactic shock—Vemurafenib—melanoma	0.00478	0.00669	CcSEcCtD
Trospium—Infection—Vemurafenib—melanoma	0.00475	0.00665	CcSEcCtD
Trospium—Nervous system disorder—Vemurafenib—melanoma	0.00469	0.00656	CcSEcCtD
Trospium—Skin disorder—Vemurafenib—melanoma	0.00465	0.0065	CcSEcCtD
Trospium—Dry skin—Temozolomide—melanoma	0.00456	0.00638	CcSEcCtD
Trospium—Breast disorder—Temozolomide—melanoma	0.0045	0.00629	CcSEcCtD
Trospium—Stomatitis—Bleomycin—melanoma	0.00443	0.00619	CcSEcCtD
Trospium—Influenza like illness—Docetaxel—melanoma	0.00443	0.00619	CcSEcCtD
Trospium—Haematuria—Bleomycin—melanoma	0.00433	0.00606	CcSEcCtD
Trospium—Abdominal distension—Temozolomide—melanoma	0.00433	0.00605	CcSEcCtD
Trospium—Fluid retention—Docetaxel—melanoma	0.00433	0.00605	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.0042	0.00588	CcSEcCtD
Trospium—Sweating increased—Temozolomide—melanoma	0.00419	0.00586	CcSEcCtD
Trospium—Decreased appetite—Vemurafenib—melanoma	0.00416	0.00582	CcSEcCtD
Trospium—Stomatitis—Dactinomycin—melanoma	0.00413	0.00578	CcSEcCtD
Trospium—Gastrointestinal disorder—Vemurafenib—melanoma	0.00413	0.00578	CcSEcCtD
Trospium—Fatigue—Vemurafenib—melanoma	0.00412	0.00577	CcSEcCtD
Trospium—Constipation—Vemurafenib—melanoma	0.00409	0.00572	CcSEcCtD
Trospium—Dysuria—Temozolomide—melanoma	0.00402	0.00562	CcSEcCtD
Trospium—Pollakiuria—Temozolomide—melanoma	0.00397	0.00555	CcSEcCtD
Trospium—Photosensitivity reaction—Temozolomide—melanoma	0.00392	0.00549	CcSEcCtD
Trospium—Weight increased—Temozolomide—melanoma	0.00391	0.00547	CcSEcCtD
Trospium—Stomatitis—Carmustine—melanoma	0.00387	0.00541	CcSEcCtD
Trospium—Urinary tract infection—Carmustine—melanoma	0.00386	0.00539	CcSEcCtD
Trospium—Infestation NOS—Temozolomide—melanoma	0.00383	0.00536	CcSEcCtD
Trospium—Infestation—Temozolomide—melanoma	0.00383	0.00536	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0038	0.00531	CcSEcCtD
Trospium—Flushing—Bleomycin—melanoma	0.00379	0.00529	CcSEcCtD
Trospium—Stomatitis—Temozolomide—melanoma	0.00374	0.00523	CcSEcCtD
Trospium—Urinary tract infection—Temozolomide—melanoma	0.00373	0.00521	CcSEcCtD
Trospium—Erythema multiforme—Dactinomycin—melanoma	0.0036	0.00503	CcSEcCtD
Trospium—Hallucination—Carmustine—melanoma	0.00354	0.00495	CcSEcCtD
Trospium—Hot flush—Docetaxel—melanoma	0.00354	0.00495	CcSEcCtD
Trospium—Flushing—Dactinomycin—melanoma	0.00353	0.00494	CcSEcCtD
Trospium—Oedema peripheral—Carmustine—melanoma	0.00351	0.00491	CcSEcCtD
Trospium—Menopausal symptoms—Docetaxel—melanoma	0.00351	0.0049	CcSEcCtD
Trospium—Connective tissue disorder—Carmustine—melanoma	0.0035	0.00489	CcSEcCtD
Trospium—Asthenia—Vemurafenib—melanoma	0.00343	0.0048	CcSEcCtD
Trospium—Visual impairment—Carmustine—melanoma	0.00343	0.0048	CcSEcCtD
Trospium—Hallucination—Temozolomide—melanoma	0.00342	0.00479	CcSEcCtD
Trospium—Urinary tract disorder—Temozolomide—melanoma	0.0034	0.00475	CcSEcCtD
Trospium—Oedema peripheral—Temozolomide—melanoma	0.00339	0.00474	CcSEcCtD
Trospium—Pruritus—Vemurafenib—melanoma	0.00338	0.00473	CcSEcCtD
Trospium—Connective tissue disorder—Temozolomide—melanoma	0.00338	0.00473	CcSEcCtD
Trospium—Urethral disorder—Temozolomide—melanoma	0.00337	0.00472	CcSEcCtD
Trospium—Eye disorder—Carmustine—melanoma	0.00333	0.00465	CcSEcCtD
Trospium—Visual impairment—Temozolomide—melanoma	0.00332	0.00464	CcSEcCtD
Trospium—Flushing—Carmustine—melanoma	0.0033	0.00462	CcSEcCtD
Trospium—Migraine—Docetaxel—melanoma	0.00326	0.00455	CcSEcCtD
Trospium—Erythema multiforme—Temozolomide—melanoma	0.00325	0.00455	CcSEcCtD
Trospium—Eye disorder—Temozolomide—melanoma	0.00322	0.0045	CcSEcCtD
Trospium—Cardiac disorder—Temozolomide—melanoma	0.00319	0.00447	CcSEcCtD
Trospium—Flushing—Temozolomide—melanoma	0.00319	0.00447	CcSEcCtD
Trospium—Dizziness—Vemurafenib—melanoma	0.00316	0.00442	CcSEcCtD
Trospium—Angiopathy—Temozolomide—melanoma	0.00312	0.00437	CcSEcCtD
Trospium—Mediastinal disorder—Temozolomide—melanoma	0.0031	0.00434	CcSEcCtD
Trospium—Malnutrition—Carmustine—melanoma	0.0031	0.00434	CcSEcCtD
Trospium—Vomiting—Vemurafenib—melanoma	0.00304	0.00425	CcSEcCtD
Trospium—Dry skin—Docetaxel—melanoma	0.00303	0.00424	CcSEcCtD
Trospium—Chest pain—Bleomycin—melanoma	0.00302	0.00423	CcSEcCtD
Trospium—Orthostatic hypotension—Docetaxel—melanoma	0.00302	0.00423	CcSEcCtD
Trospium—Abdominal pain upper—Docetaxel—melanoma	0.00302	0.00423	CcSEcCtD
Trospium—Rash—Vemurafenib—melanoma	0.00302	0.00422	CcSEcCtD
Trospium—Dermatitis—Vemurafenib—melanoma	0.00301	0.00421	CcSEcCtD
Trospium—Back pain—Carmustine—melanoma	0.003	0.00419	CcSEcCtD
Trospium—Headache—Vemurafenib—melanoma	0.003	0.00419	CcSEcCtD
Trospium—Malnutrition—Temozolomide—melanoma	0.003	0.00419	CcSEcCtD
Trospium—Breast disorder—Docetaxel—melanoma	0.00299	0.00418	CcSEcCtD
Trospium—Cramp muscle—Docetaxel—melanoma	0.00298	0.00417	CcSEcCtD
Trospium—Nasopharyngitis—Docetaxel—melanoma	0.00296	0.00414	CcSEcCtD
Trospium—Dysgeusia—Temozolomide—melanoma	0.00293	0.0041	CcSEcCtD
Trospium—Confusional state—Bleomycin—melanoma	0.00292	0.00409	CcSEcCtD
Trospium—Vision blurred—Carmustine—melanoma	0.00292	0.00409	CcSEcCtD
Trospium—Anaphylactic shock—Bleomycin—melanoma	0.0029	0.00405	CcSEcCtD
Trospium—Oedema—Bleomycin—melanoma	0.0029	0.00405	CcSEcCtD
Trospium—Back pain—Temozolomide—melanoma	0.0029	0.00405	CcSEcCtD
Trospium—Infection—Bleomycin—melanoma	0.00288	0.00403	CcSEcCtD
Trospium—Nausea—Vemurafenib—melanoma	0.00284	0.00397	CcSEcCtD
Trospium—Vision blurred—Temozolomide—melanoma	0.00282	0.00395	CcSEcCtD
Trospium—Angina pectoris—Docetaxel—melanoma	0.00279	0.00389	CcSEcCtD
Trospium—Angioedema—Temozolomide—melanoma	0.00274	0.00383	CcSEcCtD
Trospium—Oedema—Dactinomycin—melanoma	0.0027	0.00378	CcSEcCtD
Trospium—Infection—Dactinomycin—melanoma	0.00269	0.00376	CcSEcCtD
Trospium—Palpitations—Temozolomide—melanoma	0.00265	0.0037	CcSEcCtD
Trospium—Chest pain—Carmustine—melanoma	0.00264	0.00369	CcSEcCtD
Trospium—Weight increased—Docetaxel—melanoma	0.0026	0.00364	CcSEcCtD
Trospium—Confusional state—Carmustine—melanoma	0.00255	0.00357	CcSEcCtD
Trospium—Infestation NOS—Docetaxel—melanoma	0.00255	0.00356	CcSEcCtD
Trospium—Infestation—Docetaxel—melanoma	0.00255	0.00356	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00253	0.00354	CcSEcCtD
Trospium—Oedema—Carmustine—melanoma	0.00253	0.00354	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00253	0.00353	CcSEcCtD
Trospium—Decreased appetite—Bleomycin—melanoma	0.00252	0.00352	CcSEcCtD
Trospium—Infection—Carmustine—melanoma	0.00251	0.00351	CcSEcCtD
Trospium—Dry mouth—Temozolomide—melanoma	0.00249	0.00349	CcSEcCtD
Trospium—Stomatitis—Docetaxel—melanoma	0.00248	0.00347	CcSEcCtD
Trospium—Tachycardia—Carmustine—melanoma	0.00247	0.00345	CcSEcCtD
Trospium—Confusional state—Temozolomide—melanoma	0.00247	0.00345	CcSEcCtD
Trospium—Anaphylactic shock—Temozolomide—melanoma	0.00244	0.00342	CcSEcCtD
Trospium—Oedema—Temozolomide—melanoma	0.00244	0.00342	CcSEcCtD
Trospium—Infection—Temozolomide—melanoma	0.00243	0.0034	CcSEcCtD
Trospium—Nervous system disorder—Temozolomide—melanoma	0.0024	0.00335	CcSEcCtD
Trospium—Feeling abnormal—Bleomycin—melanoma	0.00239	0.00334	CcSEcCtD
Trospium—Skin disorder—Temozolomide—melanoma	0.00237	0.00332	CcSEcCtD
Trospium—Hyperhidrosis—Temozolomide—melanoma	0.00236	0.00331	CcSEcCtD
Trospium—Decreased appetite—Dactinomycin—melanoma	0.00235	0.00329	CcSEcCtD
Trospium—Fatigue—Dactinomycin—melanoma	0.00233	0.00326	CcSEcCtD
Trospium—Urticaria—Bleomycin—melanoma	0.0023	0.00322	CcSEcCtD
Trospium—Rhinitis—Docetaxel—melanoma	0.00229	0.00321	CcSEcCtD
Trospium—Urinary tract disorder—Docetaxel—melanoma	0.00226	0.00316	CcSEcCtD
Trospium—Oedema peripheral—Docetaxel—melanoma	0.00225	0.00315	CcSEcCtD
Trospium—Somnolence—Carmustine—melanoma	0.00225	0.00315	CcSEcCtD
Trospium—Connective tissue disorder—Docetaxel—melanoma	0.00225	0.00314	CcSEcCtD
Trospium—Urethral disorder—Docetaxel—melanoma	0.00224	0.00314	CcSEcCtD
Trospium—Feeling abnormal—Dactinomycin—melanoma	0.00223	0.00312	CcSEcCtD
Trospium—Gastrointestinal pain—Dactinomycin—melanoma	0.00221	0.00309	CcSEcCtD
Trospium—Visual impairment—Docetaxel—melanoma	0.00221	0.00308	CcSEcCtD
Trospium—Decreased appetite—Carmustine—melanoma	0.0022	0.00308	CcSEcCtD
Trospium—Gastrointestinal disorder—Carmustine—melanoma	0.00218	0.00305	CcSEcCtD
Trospium—Somnolence—Temozolomide—melanoma	0.00217	0.00304	CcSEcCtD
Trospium—Erythema multiforme—Docetaxel—melanoma	0.00216	0.00303	CcSEcCtD
Trospium—Constipation—Carmustine—melanoma	0.00216	0.00303	CcSEcCtD
Trospium—Dyspepsia—Temozolomide—melanoma	0.00215	0.00301	CcSEcCtD
Trospium—Eye disorder—Docetaxel—melanoma	0.00214	0.00299	CcSEcCtD
Trospium—Abdominal pain—Dactinomycin—melanoma	0.00214	0.00299	CcSEcCtD
Trospium—Decreased appetite—Temozolomide—melanoma	0.00213	0.00297	CcSEcCtD
Trospium—Flushing—Docetaxel—melanoma	0.00212	0.00297	CcSEcCtD
Trospium—Cardiac disorder—Docetaxel—melanoma	0.00212	0.00297	CcSEcCtD
Trospium—Gastrointestinal disorder—Temozolomide—melanoma	0.00211	0.00295	CcSEcCtD
Trospium—Fatigue—Temozolomide—melanoma	0.00211	0.00295	CcSEcCtD
Trospium—Constipation—Temozolomide—melanoma	0.00209	0.00292	CcSEcCtD
Trospium—Feeling abnormal—Carmustine—melanoma	0.00208	0.00292	CcSEcCtD
Trospium—Asthenia—Bleomycin—melanoma	0.00208	0.00291	CcSEcCtD
Trospium—Angiopathy—Docetaxel—melanoma	0.00208	0.0029	CcSEcCtD
Trospium—Gastrointestinal pain—Carmustine—melanoma	0.00207	0.00289	CcSEcCtD
Trospium—Mediastinal disorder—Docetaxel—melanoma	0.00206	0.00288	CcSEcCtD
Trospium—Pruritus—Bleomycin—melanoma	0.00205	0.00287	CcSEcCtD
Trospium—Feeling abnormal—Temozolomide—melanoma	0.00201	0.00282	CcSEcCtD
Trospium—Abdominal pain—Carmustine—melanoma	0.002	0.0028	CcSEcCtD
Trospium—Gastrointestinal pain—Temozolomide—melanoma	0.002	0.0028	CcSEcCtD
Trospium—Malnutrition—Docetaxel—melanoma	0.00199	0.00279	CcSEcCtD
Trospium—Dysgeusia—Docetaxel—melanoma	0.00195	0.00273	CcSEcCtD
Trospium—Urticaria—Temozolomide—melanoma	0.00194	0.00272	CcSEcCtD
Trospium—Asthenia—Dactinomycin—melanoma	0.00194	0.00271	CcSEcCtD
Trospium—Abdominal pain—Temozolomide—melanoma	0.00193	0.0027	CcSEcCtD
Trospium—Back pain—Docetaxel—melanoma	0.00193	0.00269	CcSEcCtD
Trospium—Muscle spasms—Docetaxel—melanoma	0.00192	0.00268	CcSEcCtD
Trospium—Vomiting—Bleomycin—melanoma	0.00184	0.00258	CcSEcCtD
Trospium—Rash—Bleomycin—melanoma	0.00183	0.00256	CcSEcCtD
Trospium—Dermatitis—Bleomycin—melanoma	0.00183	0.00255	CcSEcCtD
Trospium—Asthenia—Carmustine—melanoma	0.00182	0.00254	CcSEcCtD
Trospium—Syncope—Docetaxel—melanoma	0.00179	0.0025	CcSEcCtD
Trospium—Palpitations—Docetaxel—melanoma	0.00176	0.00246	CcSEcCtD
Trospium—Asthenia—Temozolomide—melanoma	0.00175	0.00245	CcSEcCtD
Trospium—Loss of consciousness—Docetaxel—melanoma	0.00175	0.00245	CcSEcCtD
Trospium—Pruritus—Temozolomide—melanoma	0.00173	0.00242	CcSEcCtD
Trospium—Nausea—Bleomycin—melanoma	0.00172	0.00241	CcSEcCtD
Trospium—Vomiting—Dactinomycin—melanoma	0.00172	0.0024	CcSEcCtD
Trospium—Rash—Dactinomycin—melanoma	0.0017	0.00238	CcSEcCtD
Trospium—Chest pain—Docetaxel—melanoma	0.0017	0.00237	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00168	0.00236	CcSEcCtD
Trospium—Dizziness—Carmustine—melanoma	0.00167	0.00234	CcSEcCtD
Trospium—Dry mouth—Docetaxel—melanoma	0.00166	0.00232	CcSEcCtD
Trospium—Confusional state—Docetaxel—melanoma	0.00164	0.00229	CcSEcCtD
Trospium—Oedema—Docetaxel—melanoma	0.00163	0.00227	CcSEcCtD
Trospium—Anaphylactic shock—Docetaxel—melanoma	0.00163	0.00227	CcSEcCtD
Trospium—Dizziness—Temozolomide—melanoma	0.00162	0.00226	CcSEcCtD
Trospium—Infection—Docetaxel—melanoma	0.00162	0.00226	CcSEcCtD
Trospium—Vomiting—Carmustine—melanoma	0.00161	0.00225	CcSEcCtD
Trospium—Nausea—Dactinomycin—melanoma	0.00161	0.00225	CcSEcCtD
Trospium—Shock—Docetaxel—melanoma	0.0016	0.00224	CcSEcCtD
Trospium—Rash—Carmustine—melanoma	0.0016	0.00223	CcSEcCtD
Trospium—Nervous system disorder—Docetaxel—melanoma	0.00159	0.00223	CcSEcCtD
Trospium—Dermatitis—Carmustine—melanoma	0.00159	0.00223	CcSEcCtD
Trospium—Tachycardia—Docetaxel—melanoma	0.00159	0.00222	CcSEcCtD
Trospium—Headache—Carmustine—melanoma	0.00158	0.00222	CcSEcCtD
Trospium—Skin disorder—Docetaxel—melanoma	0.00158	0.00221	CcSEcCtD
Trospium—Vomiting—Temozolomide—melanoma	0.00155	0.00217	CcSEcCtD
Trospium—Rash—Temozolomide—melanoma	0.00154	0.00216	CcSEcCtD
Trospium—Dermatitis—Temozolomide—melanoma	0.00154	0.00215	CcSEcCtD
Trospium—Headache—Temozolomide—melanoma	0.00153	0.00214	CcSEcCtD
Trospium—Nausea—Carmustine—melanoma	0.0015	0.0021	CcSEcCtD
Trospium—Nausea—Temozolomide—melanoma	0.00145	0.00203	CcSEcCtD
Trospium—Somnolence—Docetaxel—melanoma	0.00145	0.00202	CcSEcCtD
Trospium—Dyspepsia—Docetaxel—melanoma	0.00143	0.002	CcSEcCtD
Trospium—Decreased appetite—Docetaxel—melanoma	0.00141	0.00198	CcSEcCtD
Trospium—Gastrointestinal disorder—Docetaxel—melanoma	0.0014	0.00196	CcSEcCtD
Trospium—Fatigue—Docetaxel—melanoma	0.0014	0.00196	CcSEcCtD
Trospium—Constipation—Docetaxel—melanoma	0.00139	0.00194	CcSEcCtD
Trospium—Feeling abnormal—Docetaxel—melanoma	0.00134	0.00187	CcSEcCtD
Trospium—Gastrointestinal pain—Docetaxel—melanoma	0.00133	0.00186	CcSEcCtD
Trospium—Abdominal pain—Docetaxel—melanoma	0.00129	0.0018	CcSEcCtD
Trospium—Asthenia—Docetaxel—melanoma	0.00117	0.00163	CcSEcCtD
Trospium—Pruritus—Docetaxel—melanoma	0.00115	0.00161	CcSEcCtD
Trospium—Dizziness—Docetaxel—melanoma	0.00108	0.0015	CcSEcCtD
Trospium—Vomiting—Docetaxel—melanoma	0.00103	0.00145	CcSEcCtD
Trospium—Rash—Docetaxel—melanoma	0.00103	0.00143	CcSEcCtD
Trospium—Dermatitis—Docetaxel—melanoma	0.00102	0.00143	CcSEcCtD
Trospium—Headache—Docetaxel—melanoma	0.00102	0.00142	CcSEcCtD
Trospium—Nausea—Docetaxel—melanoma	0.000966	0.00135	CcSEcCtD
Trospium—CHRM3—Signaling Pathways—SOCS1—melanoma	7.73e-05	0.000271	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—MAP2K1—melanoma	7.71e-05	0.000271	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—S100B—melanoma	7.71e-05	0.000271	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CD—melanoma	7.69e-05	0.00027	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CD—melanoma	7.66e-05	0.000269	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SOCS1—melanoma	7.66e-05	0.000269	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—MAP2K1—melanoma	7.64e-05	0.000268	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—S100B—melanoma	7.64e-05	0.000268	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CD—melanoma	7.59e-05	0.000266	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB4—melanoma	7.4e-05	0.00026	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CB—melanoma	7.38e-05	0.000259	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB4—melanoma	7.37e-05	0.000259	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP17A1—melanoma	7.37e-05	0.000259	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CB—melanoma	7.35e-05	0.000258	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN2B—melanoma	7.33e-05	0.000257	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN2B—melanoma	7.31e-05	0.000257	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB4—melanoma	7.3e-05	0.000256	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	7.28e-05	0.000256	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN2B—melanoma	7.24e-05	0.000254	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CD86—melanoma	7.09e-05	0.000249	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCL8—melanoma	7.09e-05	0.000249	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CD86—melanoma	7.07e-05	0.000248	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCL8—melanoma	7.07e-05	0.000248	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EDN1—melanoma	7.04e-05	0.000247	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EDN1—melanoma	7.01e-05	0.000246	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CD86—melanoma	7e-05	0.000246	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCL8—melanoma	7e-05	0.000246	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GNA11—melanoma	6.96e-05	0.000244	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EDN1—melanoma	6.95e-05	0.000244	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CSF2—melanoma	6.88e-05	0.000241	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGF1—melanoma	6.88e-05	0.000241	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGF1—melanoma	6.86e-05	0.000241	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CSF2—melanoma	6.86e-05	0.000241	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—FASN—melanoma	6.81e-05	0.000239	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGF1—melanoma	6.79e-05	0.000238	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CSF2—melanoma	6.79e-05	0.000238	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—IL2—melanoma	6.78e-05	0.000238	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—IL2—melanoma	6.75e-05	0.000237	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—E2F1—melanoma	6.73e-05	0.000236	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—E2F1—melanoma	6.71e-05	0.000235	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CB—melanoma	6.7e-05	0.000235	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC5A5—melanoma	6.7e-05	0.000235	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—IL2—melanoma	6.69e-05	0.000235	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CB—melanoma	6.68e-05	0.000234	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PDGFRA—melanoma	6.66e-05	0.000234	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—E2F1—melanoma	6.64e-05	0.000233	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PDGFRA—melanoma	6.64e-05	0.000233	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CB—melanoma	6.61e-05	0.000232	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ITGB3—melanoma	6.59e-05	0.000231	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PRKCA—melanoma	6.59e-05	0.000231	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PDGFRA—melanoma	6.58e-05	0.000231	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PRKCA—melanoma	6.57e-05	0.000231	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ITGB3—melanoma	6.57e-05	0.000231	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PRKCA—melanoma	6.51e-05	0.000228	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ITGB3—melanoma	6.51e-05	0.000228	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GNAQ—melanoma	6.47e-05	0.000227	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CD44—melanoma	6.47e-05	0.000227	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SPP1—melanoma	6.47e-05	0.000227	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAP2K2—melanoma	6.45e-05	0.000226	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SPP1—melanoma	6.45e-05	0.000226	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL8—melanoma	6.44e-05	0.000226	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAP2K2—melanoma	6.43e-05	0.000226	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL8—melanoma	6.42e-05	0.000225	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SPP1—melanoma	6.38e-05	0.000224	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAP2K2—melanoma	6.36e-05	0.000223	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL8—melanoma	6.36e-05	0.000223	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1B1—melanoma	6.2e-05	0.000218	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CG—melanoma	6.16e-05	0.000216	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL2—melanoma	6.15e-05	0.000216	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL2—melanoma	6.13e-05	0.000215	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TERT—melanoma	6.13e-05	0.000215	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—RAC1—melanoma	6.11e-05	0.000215	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TERT—melanoma	6.11e-05	0.000214	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—RAC1—melanoma	6.09e-05	0.000214	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL2—melanoma	6.07e-05	0.000213	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TERT—melanoma	6.05e-05	0.000212	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—RAC1—melanoma	6.03e-05	0.000212	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PPARG—melanoma	5.94e-05	0.000209	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HIF1A—melanoma	5.86e-05	0.000206	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HIF1A—melanoma	5.84e-05	0.000205	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HIF1A—melanoma	5.79e-05	0.000203	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KDR—melanoma	5.61e-05	0.000197	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KDR—melanoma	5.59e-05	0.000196	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KDR—melanoma	5.53e-05	0.000194	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CD—melanoma	5.41e-05	0.00019	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FN1—melanoma	5.4e-05	0.000189	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FN1—melanoma	5.38e-05	0.000189	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALB—melanoma	5.34e-05	0.000188	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FN1—melanoma	5.33e-05	0.000187	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOTCH1—melanoma	5.28e-05	0.000185	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOTCH1—melanoma	5.26e-05	0.000185	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOTCH1—melanoma	5.21e-05	0.000183	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CD80—melanoma	5.17e-05	0.000182	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—APC—melanoma	5.16e-05	0.000181	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KIT—melanoma	5.16e-05	0.000181	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CG—melanoma	5.16e-05	0.000181	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—NRAS—melanoma	5.16e-05	0.000181	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CD80—melanoma	5.16e-05	0.000181	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—APC—melanoma	5.15e-05	0.000181	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CG—melanoma	5.15e-05	0.000181	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KIT—melanoma	5.15e-05	0.000181	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—NRAS—melanoma	5.15e-05	0.000181	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CD80—melanoma	5.11e-05	0.000179	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ABCB1—melanoma	5.11e-05	0.000179	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGF—melanoma	5.11e-05	0.000179	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CG—melanoma	5.1e-05	0.000179	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—APC—melanoma	5.1e-05	0.000179	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KIT—melanoma	5.1e-05	0.000179	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—NRAS—melanoma	5.1e-05	0.000179	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGF—melanoma	5.09e-05	0.000179	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGF—melanoma	5.04e-05	0.000177	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—MAPK3—melanoma	4.95e-05	0.000174	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—MAPK3—melanoma	4.93e-05	0.000173	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—MAPK3—melanoma	4.88e-05	0.000171	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—BRAF—melanoma	4.85e-05	0.00017	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—BRAF—melanoma	4.84e-05	0.00017	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—BRAF—melanoma	4.79e-05	0.000168	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IGF1—melanoma	4.73e-05	0.000166	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CB—melanoma	4.72e-05	0.000166	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IGF1—melanoma	4.71e-05	0.000165	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—MAPK1—melanoma	4.71e-05	0.000165	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—EGFR—melanoma	4.71e-05	0.000165	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PRKCA—melanoma	4.7e-05	0.000165	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—MAPK1—melanoma	4.69e-05	0.000165	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—EGFR—melanoma	4.69e-05	0.000165	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTGS2—melanoma	4.67e-05	0.000164	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IGF1—melanoma	4.67e-05	0.000164	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ERCC2—melanoma	4.66e-05	0.000164	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—MAPK1—melanoma	4.65e-05	0.000163	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—EGFR—melanoma	4.64e-05	0.000163	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAP2K1—melanoma	4.57e-05	0.00016	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAP2K1—melanoma	4.56e-05	0.00016	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CD—melanoma	4.54e-05	0.000159	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CD—melanoma	4.53e-05	0.000159	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAP2K1—melanoma	4.51e-05	0.000158	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	4.5e-05	0.000158	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	4.48e-05	0.000157	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CD—melanoma	4.48e-05	0.000157	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—KRAS—melanoma	4.45e-05	0.000156	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	4.44e-05	0.000156	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—KRAS—melanoma	4.43e-05	0.000156	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—KRAS—melanoma	4.39e-05	0.000154	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGF2—melanoma	4.35e-05	0.000153	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGF2—melanoma	4.33e-05	0.000152	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGF2—melanoma	4.29e-05	0.000151	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CA—melanoma	4.08e-05	0.000143	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTEN—melanoma	4.08e-05	0.000143	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CA—melanoma	4.07e-05	0.000143	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MDM2—melanoma	4.07e-05	0.000143	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MDM2—melanoma	4.05e-05	0.000142	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CA—melanoma	4.03e-05	0.000141	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MDM2—melanoma	4.02e-05	0.000141	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB2—melanoma	4.01e-05	0.000141	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB2—melanoma	4e-05	0.00014	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB2—melanoma	3.96e-05	0.000139	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CB—melanoma	3.96e-05	0.000139	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CB—melanoma	3.94e-05	0.000138	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CB—melanoma	3.91e-05	0.000137	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL8—melanoma	3.8e-05	0.000133	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL8—melanoma	3.79e-05	0.000133	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—HRAS—melanoma	3.78e-05	0.000133	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—HRAS—melanoma	3.77e-05	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL8—melanoma	3.75e-05	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—HRAS—melanoma	3.73e-05	0.000131	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1B—melanoma	3.71e-05	0.00013	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1B—melanoma	3.7e-05	0.00013	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CG—melanoma	3.68e-05	0.000129	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—AKT1—melanoma	3.67e-05	0.000129	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1B—melanoma	3.67e-05	0.000129	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—AKT1—melanoma	3.66e-05	0.000129	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CASP3—melanoma	3.64e-05	0.000128	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL2—melanoma	3.63e-05	0.000128	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CASP3—melanoma	3.63e-05	0.000127	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.63e-05	0.000127	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL2—melanoma	3.62e-05	0.000127	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL6—melanoma	3.62e-05	0.000127	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL6—melanoma	3.6e-05	0.000127	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CASP3—melanoma	3.59e-05	0.000126	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL2—melanoma	3.59e-05	0.000126	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL6—melanoma	3.57e-05	0.000125	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PPARG—melanoma	3.55e-05	0.000125	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCND1—melanoma	3.54e-05	0.000124	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCND1—melanoma	3.53e-05	0.000124	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CTNNB1—melanoma	3.51e-05	0.000123	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCND1—melanoma	3.5e-05	0.000123	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CTNNB1—melanoma	3.5e-05	0.000123	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.46e-05	0.000122	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MMP9—melanoma	3.44e-05	0.000121	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MMP9—melanoma	3.43e-05	0.00012	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1A—melanoma	3.43e-05	0.00012	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PTEN—melanoma	3.42e-05	0.00012	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1A—melanoma	3.42e-05	0.00012	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PTEN—melanoma	3.41e-05	0.00012	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NFKB1—melanoma	3.4e-05	0.000119	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MMP9—melanoma	3.4e-05	0.000119	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NFKB1—melanoma	3.39e-05	0.000119	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.38e-05	0.000119	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PTEN—melanoma	3.38e-05	0.000118	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NFKB1—melanoma	3.36e-05	0.000118	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—AKT1—melanoma	3.34e-05	0.000117	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—AKT1—melanoma	3.33e-05	0.000117	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—AKT1—melanoma	3.29e-05	0.000116	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CD—melanoma	3.24e-05	0.000114	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALB—melanoma	3.19e-05	0.000112	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—VEGFA—melanoma	3.09e-05	0.000108	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—VEGFA—melanoma	3.08e-05	0.000108	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—STAT3—melanoma	3.06e-05	0.000107	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NRAS—melanoma	3.05e-05	0.000107	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—VEGFA—melanoma	3.05e-05	0.000107	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—STAT3—melanoma	3.05e-05	0.000107	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NRAS—melanoma	3.04e-05	0.000107	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—STAT3—melanoma	3.02e-05	0.000106	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NRAS—melanoma	3.01e-05	0.000106	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAPK3—melanoma	2.92e-05	0.000103	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAPK3—melanoma	2.91e-05	0.000102	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAPK3—melanoma	2.88e-05	0.000101	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CA—melanoma	2.88e-05	0.000101	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MYC—melanoma	2.84e-05	9.97e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MYC—melanoma	2.83e-05	9.94e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CB—melanoma	2.82e-05	9.9e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MYC—melanoma	2.81e-05	9.85e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTGS2—melanoma	2.8e-05	9.81e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAPK1—melanoma	2.78e-05	9.76e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGFR—melanoma	2.78e-05	9.76e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAPK1—melanoma	2.77e-05	9.73e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGFR—melanoma	2.77e-05	9.72e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAPK1—melanoma	2.74e-05	9.63e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGFR—melanoma	2.74e-05	9.63e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KRAS—melanoma	2.63e-05	9.22e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KRAS—melanoma	2.62e-05	9.19e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KRAS—melanoma	2.59e-05	9.1e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTEN—melanoma	2.44e-05	8.55e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.41e-05	8.47e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.4e-05	8.44e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.38e-05	8.36e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—AKT1—melanoma	2.35e-05	8.25e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TP53—melanoma	2.33e-05	8.19e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TP53—melanoma	2.33e-05	8.16e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TP53—melanoma	2.3e-05	8.09e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HRAS—melanoma	2.23e-05	7.83e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HRAS—melanoma	2.22e-05	7.81e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HRAS—melanoma	2.2e-05	7.73e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL6—melanoma	2.14e-05	7.5e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL6—melanoma	2.13e-05	7.47e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL6—melanoma	2.11e-05	7.4e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKT1—melanoma	1.97e-05	6.92e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKT1—melanoma	1.96e-05	6.89e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKT1—melanoma	1.95e-05	6.83e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CA—melanoma	1.72e-05	6.04e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—AKT1—melanoma	1.4e-05	4.93e-05	CbGpPWpGaD
